Cáncer de Próstata

An analysis of Brazil's public health system shows that orchiectomy could generate massive savings compared to chemical castration for metastatic prostate cancer, freeing up resources to expand access to innovative therapies like abiraterone.

A global analysis shows that while prostate cancer mortality is decreasing in many countries thanks to PSA testing and better treatments, Latin America continues to face high mortality rates and significant inequalities in access to diagnosis and therapy.

Universal germline genetic testing for prostate cancer could detect up to 42% more hereditary variants that currently go unnoticed under existing criteria, improving the identification of at-risk patients and their family members.